Browse Category

Analyst Insights News 14 December 2025 - 16 December 2025

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is back on traders’ radars on December 16, 2025, after a sharp, high-volume move that has pushed the clinical-stage biotech into “crowded trade” territory—where catalysts, liquidity, and sentiment can matter as much as fundamentals. As
Core Scientific (CORZ) Stock Drops on Dec. 15, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching

Core Scientific (CORZ) Stock Drops on Dec. 15, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching

Core Scientific, Inc. (NASDAQ: CORZ) stock traded sharply lower on Monday, December 15, 2025, as investors recalibrated risk across crypto- and AI-infrastructure-linked names. By mid-afternoon, CORZ was hovering around $15.2–$15.3, down roughly 7%–8% on the session after opening near $16.50.
Rheinmetall Aktie Today (15 December 2025): Share Price Slides on Berlin Peace Talks, Despite Tank Megaproject Approval and Bullish Analyst Targets

Rheinmetall Aktie Today (15 December 2025): Share Price Slides on Berlin Peace Talks, Despite Tank Megaproject Approval and Bullish Analyst Targets

Rheinmetall Aktie (Rheinmetall AG shares) traded lower on Monday, 15 December 2025, as markets digested fresh developments around high-level Ukraine talks in Berlin—headlines that have recently been enough to move Europe’s defence stocks even when company fundamentals remain strong. By late
Nvidia Stock (NVDA) Before the Market Opens Dec. 15, 2025: Latest News, Key Catalysts, Analyst Targets, and Risks

Nvidia Stock (NVDA) Before the Market Opens Dec. 15, 2025: Latest News, Key Catalysts, Analyst Targets, and Risks

Nvidia stock heads into the Monday, Dec. 15, 2025 U.S. market open with investors balancing two powerful—and competing—forces: the company’s still-dominant position in AI infrastructure, and a fresh wave of market anxiety about whether the AI boom is getting ahead of fundamentals.
1 18 19 20 21 22 25
Go toTop